Reply to: Comment on The Study of NRG258: Limitations and Future Directions

Daniela Matei

doi:10.1200/JCO-25-00473

Reply to: Comment on The Study of NRG258: Limitations and Future Directions

Daniela Matei

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2450-2451
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	43
Issue number	21
DOIs	https://doi.org/10.1200/JCO-25-00473
State	Published - Jul 20 2025

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO-25-00473

Cite this

@article{6f363e89a22c4552bec5a31a7c27efb1,

title = "Reply to: Comment on The Study of NRG258: Limitations and Future Directions",

author = "Daniela Matei",

year = "2025",

month = jul,

day = "20",

doi = "10.1200/JCO-25-00473",

language = "English (US)",

volume = "43",

pages = "2450--2451",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "21",

}

TY - JOUR

T1 - Reply to

T2 - Comment on The Study of NRG258: Limitations and Future Directions

AU - Matei, Daniela

PY - 2025/7/20

Y1 - 2025/7/20

UR - https://www.scopus.com/pages/publications/105003312441

UR - https://www.scopus.com/inward/citedby.url?scp=105003312441&partnerID=8YFLogxK

U2 - 10.1200/JCO-25-00473

DO - 10.1200/JCO-25-00473

M3 - Letter

C2 - 40209126

AN - SCOPUS:105003312441

SN - 0732-183X

VL - 43

SP - 2450

EP - 2451

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 21

ER -

Reply to: Comment on The Study of NRG258: Limitations and Future Directions

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this